BlackRock’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $304M | Buy |
20,868,362
+910,860
| +5% | +$8.79M | ﹤0.01% | 1537 |
|
|
2026
Q1 | $148M | Buy |
19,957,502
+496,153
| +3% | +$5.22M | ﹤0.01% | 1861 |
|
|
2025
Q4 | $229M | Buy |
19,461,349
+162,420
| +0.8% | +$1.75M | ﹤0.01% | 1595 |
|
|
2025
Q3 | $149M | Sell |
19,298,929
-125,659
| -0.6% | -$880K | ﹤0.01% | 1842 |
|
|
2025
Q2 | $142M | Sell |
19,424,588
-439,838
| -2% | -$3.55M | ﹤0.01% | 1824 |
|
|
2025
Q1 | $189M | Sell |
19,864,426
-379,241
| -2% | -$4.74M | ﹤0.01% | 1630 |
|
|
2024
Q4 | $334M | Buy |
20,243,667
+332,324
| +2% | +$5.16M | 0.01% | 1362 |
|
|
2024
Q3 | $294M | Buy |
19,911,343
+241,269
| +1% | +$3.78M | 0.01% | 1439 |
|
|
2024
Q2 | $273M | Sell |
19,670,074
-180,790
| -0.9% | -$2.56M | 0.01% | 1409 |
|
|
2024
Q1 | $312M | Sell |
19,850,864
-130,129
| -0.7% | -$2.01M | 0.01% | 1339 |
|
|
2023
Q4 | $323M | Sell |
19,980,993
-121,915
| -0.6% | -$1.99M | 0.01% | 1323 |
|
|
2023
Q3 | $247M | Sell |
20,102,908
-673,304
| -3% | -$10M | 0.01% | 1401 |
|
|
2023
Q2 | $334M | Sell |
20,776,212
-532,168
| -2% | -$8.77M | 0.01% | 1212 |
|
|
2023
Q1 | $371M | Sell |
21,308,380
-625,097
| -3% | -$8.9M | 0.01% | 1127 |
|
|
2022
Q4 | $203M | Buy |
21,933,477
+824,295
| +4% | +$7.68M | 0.01% | 1520 |
|
|
2022
Q3 | $182M | Buy |
21,109,182
+79,055
| +0.4% | +$785K | 0.01% | 1548 |
|
|
2022
Q2 | $171M | Buy |
21,030,127
+1,440,078
| +7% | +$13.7M | 0.01% | 1644 |
|
|
2022
Q1 | $238M | Buy |
19,590,049
+261,795
| +1% | +$5.51M | 0.01% | 1538 |
|
|
2021
Q4 | $659M | Buy |
19,328,254
+569,039
| +3% | +$22.3M | 0.02% | 823 |
|
|
2021
Q3 | $905M | Buy |
18,759,215
+36,710
| +0.2% | +$1.7M | 0.03% | 621 |
|
|
2021
Q2 | $846M | Sell |
18,722,505
-18,621
| -0.1% | -$825K | 0.02% | 673 |
|
|
2021
Q1 | $904M | Buy |
18,741,126
+1,494,556
| +9% | +$77.8M | 0.03% | 637 |
|
|
2020
Q4 | $929M | Buy |
17,246,570
+861,490
| +5% | +$38.9M | 0.03% | 561 |
|
|
2020
Q3 | $604M | Sell |
16,385,080
-291,155
| -2% | -$10.8M | 0.02% | 650 |
|
|
2020
Q2 | $517M | Buy |
16,676,235
+1,364,731
| +9% | +$37.8M | 0.02% | 697 |
|
|
2020
Q1 | $423M | Sell |
15,311,504
-277,628
| -2% | -$8.32M | 0.02% | 699 |
|
|
2019
Q4 | $456M | Buy |
15,589,132
+273,141
| +2% | +$6.5M | 0.02% | 856 |
|
|
2019
Q3 | $293M | Buy |
15,315,991
+390,664
| +3% | +$9.16M | 0.01% | 1130 |
|
|
2019
Q2 | $327M | Buy |
14,925,327
+1,100,263
| +8% | +$24.1M | 0.01% | 1066 |
|
|
2019
Q1 | $283M | Buy |
13,825,064
+8,305,417
| +150% | +$144M | 0.01% | 1153 |
|
|
2018
Q4 | $69.6M | Buy |
5,519,647
+440,621
| +9% | +$6.57M | ﹤0.01% | 2037 |
|
|
2018
Q3 | $78M | Buy |
5,079,026
+929,697
| +22% | +$12.9M | ﹤0.01% | 2129 |
|
|
2018
Q2 | $54.4M | Buy |
4,149,329
+184,386
| +5% | +$2.03M | ﹤0.01% | 2309 |
|
|
2018
Q1 | $32.4M | Buy |
3,964,943
+12,147
| +0.3% | +$98.4K | ﹤0.01% | 2511 |
|
|
2017
Q4 | $35M | Buy |
3,952,796
+54,998
| +1% | +$507K | ﹤0.01% | 2480 |
|
|
2017
Q3 | $43.4M | Buy |
3,897,798
+476,681
| +14% | +$4.64M | ﹤0.01% | 2368 |
|
|
2017
Q2 | $30.7M | Buy |
3,421,117
+90,861
| +3% | +$721K | ﹤0.01% | 2538 |
|
|
2017
Q1 | $26.3M | Buy |
3,330,256
+3,326,005
| +78,241% | +$27.1M | ﹤0.01% | 2601 |
|
|
2016
Q4 | $36K | Sell |
4,251
-484
| -10% | -$4.15K | ﹤0.01% | 3070 |
|
|
2016
Q3 | $39K | Buy |
4,735
+317
| +7% | +$2.66K | ﹤0.01% | 3081 |
|
|
2016
Q2 | $35K | Buy |
4,418
+722
| +20% | +$5.79K | ﹤0.01% | 3079 |
|
|
2016
Q1 | $25K | Buy |
3,696
+2,272
| +160% | +$15K | ﹤0.01% | 2743 |
|
|
2015
Q4 | $11K | Hold |
1,424
| – | – | ﹤0.01% | 2849 |
|
|
2015
Q3 | $8K | Hold |
1,424
| – | – | ﹤0.01% | 2833 |
|
|
2015
Q2 | $8K | Buy |
+1,424
| New | +$7.34K | ﹤0.01% | 2923 |
|
Other funds holding NEO
FLAM
GF
NAMI
B
BlackRock's NEO Position: Q2 2026 in Review
BlackRock increased its NeoGenomics (NEO) stake by 4.6% in Q2 2026, buying an estimated $8.79M and bringing the position to 20,868,362 shares worth $304M. The position accounts for ﹤0.01% of the portfolio, ranked #1537.
BlackRock first reported a position in NEO in Q2 2015 and has held it in 45 quarters since. The position peaked at $929M in Q4 2020. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- BlackRock held 20,868,362 shares of NeoGenomics worth $304M as of Q2 2026.
- BlackRock bought 910,860 NeoGenomics shares in Q2 2026, an estimated $8.79M.
- NeoGenomics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #1537 holding.
- BlackRock first reported a position in NeoGenomics in Q2 2015 and has held it in 45 quarters since.
- BlackRock's NeoGenomics position peaked at $929M in Q4 2020.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.